Rational approach to the treatment of EGFR-positive lung cancer

by E. V. Reutova, K. K. Laktionov, D. I. Yudin, M. S. Ardzinba
Published 2019-12-01

A clinical case of treatment of a patient with acute adrenal insufficiency after combined immunotherapy (nivolumab + ipilimumab). Prospects for a return to immunotherapy after seve...

by К. К. Laktionov, К. А. Sarantseva, D. I. Yudin, М. F. Beloyartseva, G. S. Yunaev
Published 2021-06-01

Clinical case of use of osimertinib in a patient with disseminated EGFR-mutated non-small cell lung cancer in the first-line therapy

by K. A. Sarantseva, K. K. Laktionov, E. V. Reutova, D. I. Yudin, V. V. Breder
Published 2020-12-01

Three-year results of application of nivolumab in patients with non-small cell lung cancer in clinical practice of the N.N. Blokhin Russian Cancer Research Center

by K. K. Laktionov, K. A. Sarantseva, D. I. Yudin, V. V. Breder, E. V. Reutova, K. P. Laktionov
Published 2019-12-01

A clinical case of 3-year highly efficient pembrolizamable therapy of metasatic lung adenocarcinoma

by K. K. Laktionov, D. I. Yudin, K. A. Sarantseva, K. P. Laktionov, V. V. Breder, E. V. Reutova
Published 2018-07-01

A case report of immune-related pneumonitis after combined treatment of non small cell lung cancer

by E. S. Denisova, M. S. Ardzinba, K. K. Laktionov, D. I. Yudin, K. A. Sarantseva, G. V. Shcherbakova, N. V. Marinichenko
Published 2020-07-01

Abscopal effect in a patient with metastatic NSCLC following a course of radiation therapy to the brain

by E. S. Denisova, K. K. Laktionov, T. N. Borisova, Merab. S. Ardzinba, A. A. Fedorova, D. I. Yudin, S. S. Magamedova, Milada A. Ardzinba
Published 2020-12-01

Pseudoprogression in patients on immunotherapy

by D. I. Yudin, K. K. Laktionov, K. A. Sarantseva, V. V. Breder, E. V. Reutova, O. I. Borisova, M. S. Ardzinba
Published 2019-06-01

Phenotypic transformation as a cause of secondary drug resistance to osimetinib clinical observation

by L. A. Nelyubina, E. V. Reutova, K. K. Laktionov, D. I. Yudin, D. T. Marinov, E. N. Kozak, V. V. Mochalnikova
Published 2018-11-01

A preliminary results of integrated chemotherapy with EGFR receptor tyrosine kinase inhibitors in patients with non-small-cell-lung cancer harboring EGFR mutation

by K. K. Laktionov, D. I. Yudin, V. V. Breder, E. V. Reutova, K. P. Laktionov, D. T. Marinov, D. A. Peregudov, M. S. Ardzinba
Published 2019-06-01

Will neo-adjuvant immunotherapy become a new paradigm in the treatment of lung cancer patients

by K. K. Laktionov, V. V. Breder, D. I. Yudin, K. A. Sarantseva, L. V. Laktionova, M. S. Ardzinba, E. V. Reutova, A. V. Egorova
Published 2019-12-01

Combined chemoradiotherapy regimens and their effectiveness in the treatment of patients with non-small-cell unresectable stage III lung cancer: review of literature

by N. V. Marinichenko, K. K. Laktionov, A. V. Nazarenko, V. V. Breder, T. N. Borisova, D. I. Yudin, M. S. Ardzinba, A. V. Egorova, A. A. Fedorova
Published 2019-06-01

Immuno-related endocrinopathy in patients treated with immune checkpoint inhibitors

by D. I. Yudin, K. K. Laktionov, K. A. Sarantseva, O. I. Borisova, V. V. Breder, E. V. Reutova, M. F. Beloyartseva, S. Yu. Kruteleva, I. A. Dzhanyan
Published 2020-07-01

New possibilities in the treatment of EGFR mutation-positive non-small-cell lung cancer patients after the progression on a 1st and 2nd generation EGFR tyrosine kinase inhibitors

by K K Laktionov, E V Reutova, L A Nelyubina, M Yu Pitkevich, M A Okruzhnova, M S Ardzinba, D I Yudin, I A Demidova, A R Zaretsky
Published 2018-06-01

Intermediate results of combination therapy in patients with oligometastatic non-small cell lung cancer

by D. I. Yudin, K. K. Laktionov, D. T. Marinov, V. V. Breder, A. K. Allakhverdiev, T. N. Borisova, A. H. Bekyashev, K. P. Laktionov, V. A. Aleshin, M. S. Ardzinba
Published 2018-11-01